[1]许恬逸,董瑞.儿童卵黄囊瘤病因研究进展[J].临床小儿外科杂志,2021,20(12):1194-1200.[doi:10.12260/lcxewkzz.2021.12.018]
 Xu Tianyi,Dong Rui.Advances in etiology of yolk sac tumor in children[J].Journal of Clinical Pediatric Surgery,2021,20(12):1194-1200.[doi:10.12260/lcxewkzz.2021.12.018]
点击复制

儿童卵黄囊瘤病因研究进展

参考文献/References:

1 施全, 王凤华, 高秋, 等.儿童及青少年卵黄囊瘤的临床病理分析[J].中国妇幼健康研究, 2019, 30(3):342-346.DOI:10.3969/j.issn.1673-5293.2019.03.019. Shi Q, Wang FH, Gao Q, et al.Clinicopathological analysis of yolk sac tumor in children and adolescents[J].Chinese Journal of Woman and Child Health Research, 2019, 30(3):342-346.DOI:10.3969/j.issn.1673-5293.2019.03.019.
2 吕敏, 张浩川, 同毓龙, 等.婆娑双树基因4干扰载体对儿童睾丸卵黄囊瘤的转染及干扰效果评价[J].中华小儿外科杂志, 2016, 37(9):673-676.DOI:10.3760/cma.j.issn.0253-3006.2016.09.008. Lü M, Zhang HC, Tong YL, et al.Efficacy of RNA interference after a transfection of SALL4 shRNA vector in pediatric testicular yolk sac tumor[J].Chin J Pediatr Surg, 2016, 37(9):673-676.DOI:10.3760/cma.j.issn.0253-3006.2016.09.008.
3 李晓明, 邓敏, 向进, 等.儿童盆腔卵黄囊瘤的64层螺旋CT诊断与临床病理对照分析[J].临床小儿外科杂志, 2016, 15(4):411-413.DOI:10.3969/j.issn.1671-6353.2016.04.029. Li XM, Deng M, Xiang J, et al.Multi-slice computed tomography diagnosis and clinicopathological characteristics of ovarian yolk sac tumor[J].J Clin Ped Sur, 2016, 15(4):411-413.DOI:10.3969/j.issn.1671-6353.2016.04.029.
4 Tatetsu H, Kong NR, Chong G, et al.SALL4, the missing link between stem cells, development and cancer[J].Gene, 2016, 584(2):111-119.DOI:10.1016/j.gene.2016.02.019.
5 Miettinen M, Wang Z, Mccue PA, et al.SALL4 Expression in Germ Cell and Non-Germ Cell Tumors[J].Am J Surg Pathol, 2014, 38(3):410-420.DOI:10.1097/PAS.0000000000000116.
6 Bradshaw A, Wickremesekera A, Brasch HD, et al.Cancer Stem Cells in Glioblastoma Multiforme[J].Front Surg, 2016, 3:48.DOI:10.3389/fsurg.2016.00048.
7 Cao DF, Li JP, Guo CC, et al.SALL4 is a novel diagnostic marker for testicular germ cell tumors[J].Am J Surg Pathol, 2009, 33(7):1065-1077.DOI:10.1097/PAS.0b013e3181a13eef.
8 Wang F, Liu A, Peng Y, et al.Diagnostic utility of SALL4 in extragonadal yolk sac tumors:an immunohistochemical study of 59 cases with comparison to placental-like alkaline phosphatase, alpha-fetoprotein, and glypican-3[J].Am J Surg Pathol, 2009, 33(10):1529-1539.DOI:10.1097/PAS.0b013e3181ad25d5.
9 Liu C, Wu H, Li Y, et al.SALL4 suppresses PTEN expression to promote glioma cell proliferation via PI3K/AKT signaling pathway[J].J Neurooncol, 2017, 35(2):263-272.DOI:10.1007/s11060-017-2589-3.
10 Zhang X, Yuan X, Zhu W, et al.SALL4:An emerging cancer biomarker and target[J].Cancer Lett, 2015, 357(1):55-62.DOI:10.1016/j.canlet.2014.11.037.
11 Yang J, Gao C, Chai L, et al.A novel SALL4/OCT4 transcriptional feedback network for pluripotency of embryonic stem cells[J].PLoS One, 2010, 5(5):e10766.DOI:10.1371/journal.pone.0010766.
12 Chan AL, La HM, Legrand J, et al.Germline Stem Cell Activity Is Sustained by SALL4-Dependent Silencing of Distinct Tumor Suppressor Genes[J].Stem Cell Reports, 2017, 9(3):956-971.DOI:10.1016/j.stemcr.2017.08.001.
13 She Z, Yang W.SOX family transcription factors involved in diverse cellular events during development[J].Eur J Cell Biol, 2015, 94(12):547-563.DOI:10.1016/j.ejcb.2015.08.002.
14 Kumar P, Mistri TK.Transcription factors in SOX family:Potent regulators for cancer initiation and development in the human body[J].Semin Cancer Biol, 2020, 67(1):105-113.DOI:10.1016/j.semcancer.2019.06.016.
15 Liu K, Lin B, Zhao M, et al.The multiple roles for Sox2 in stem cell maintenance and tumorigenesis[J].Cell Signal, 2013, 25(5):1264-1271.DOI:10.1016/j.cellsig.2013.02.013.
16 Wu F, Zhang J, Wang P, et al.Identification of two novel phenotypically distinct breast cancer cell subsets based on Sox2 transcription activity[J].Cell Signal, 2012, 24(11):1989-1998.DOI:10.1016/j.cellsig.2012.07.008.
17 Xiang R, Liao D, Cheng T, et al.Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer[J].Br J Cancer, 2011, 104(9):1410-1417.DOI:10.1038/bjc.2011.94.
18 Otsubo T, Akiyama Y, Hashimoto Y, et al.MicroRNA-126 inhibits SOX2 expression and contributes to gastric carcinogenesis[J].PLoS One, 2011, 6(1):e16617.DOI:10.1371/journal.pone.0016617.
19 Jeon HM, Sohn YW, Oh SY, et al.ID4 Imparts chemoresistance and cancer stemness to glioma cells by derepressing miR-9*-mediated suppression of SOX2[J].Cancer Res, 2011, 71(9):3410-3421.DOI:10.1158/0008-5472.CAN-10-3340.
20 Liu T, Cheng W, Huang Y, et al.Human amniotic epithelial cell feeder layers maintain human iPS cell pluripotency via inhibited endogenous microRNA-145 and increased Sox2 expression[J].Exp Cell Res, 2012, 318(4):424-434.DOI:10.1016/j.yexcr.2011.12.004.
21 Fang X, Yoon JG, Li L, et al.The SOX2 response program in glioblastoma multiforme:an integrated ChIP-seq, expression microarray, and microRNA analysis[J].BMC Genomics, 2011, 12:11.DOI:10.1186/1471-2164-12-11.
22 Chew LJ, Shen W, Ming X, et al.SRY-Box Containing Gene 17 Regulates the Wnt/-Catenin Signaling Pathway in Oligodendrocyte Progenitor Cells[J].J Neurosci, 2011, 31(39):13921-13935.DOI:10.1523/JNEUROSCI.3343-11.2011.
23 Kormish JD, Sinner D, Zorn AM.Interactions between SOX factors and Wnt/β-catenin signaling in development and disease[J].Dev Dyn, 2010, 239(1):56-68.DOI:10.1002/dvdy.22046.
24 Tan DS, Holzner M, Weng M, et al.SOX17 in cellular reprogramming and cancer[J].Semin Cancer Biol, 2020, 67(1):65-73.DOI:10.1016/j.semcancer.2019.08.008.
25 Suzuki J, Azuma N, Dateki S, et al.Mutation spectrum and phenotypic variation in nine patients with SOX2 abnormalities[J].J Hum Genet, 2014, 59(6):353-356.DOI:10.1038/jhg.2014.34.
26 Li C, Yan Y, Ji W, et al.OCT4 positively regulates Survivin expression to promote cancer cell proliferation and leads to poor prognosis in esophageal squamous cell carcinoma[J].PLoS One, 2012, 7(11):e49693.DOI:10.1371/journal.pone.0049693.
27 Liu Y, Timani K, Ou X, et al.C-MYC controlled TIP110 protein expression regulates OCT4 mRNA splicing in human embryonic stem cells[J].Stem Cells Dev, 2013, 22(5):689-694.DOI:10.1089/scd.2012.0271.
28 Lin H, Sun L, Han W, et al.Knockdown of OCT4 suppresses the growth and invasion of pancreatic cancer cells through inhibition of the AKT pathway[J].Mol Med Rep, 2014, 10(3):1335-1342.DOI:10.3892/mmr.2014.2367.
29 Lin Y, Yang Y, Li W, et al.Reciprocal regulation of Akt and Oct4 promotes the self-renewal and survival of embryonal carcinoma cells[J].Mol Cell, 2012, 48(4):627-640.DOI:10.1016/j.molcel.2012.08.030.
30 Zhao QW, Zhou YW, Li WX, et al.Akt-mediated phosphorylation of Oct4 is associated with the proliferation of stemlike cancer cells[J].Oncol Rep, 2015, 33(4):1621-1629.DOI:10.3892/or.2015.3752.
31 Wang XQ, Ongkeko WM, Chen L, et al.Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4-AKT-ATP-binding cassette G2 pathway[J].Hepatology, 2010, 52(2):528-539.DOI:10.1002/hep.23692.
32 Huang Y.A mirror of two faces:Lin28 as a master regulator of both miRNA and mRNA[J].Wiley Interdiscip Rev RNA, 2012, 3(4):483-494.DOI:10.1002/wrna.1112.
33 Shyh-Chang N, Daley GQ.Lin28:Primal Regulator of Growth and Metabolism in Stem Cells[J].Cell Stem Cell, 2013, 12(4):395-406.DOI:10.1016/j.stem.2013.03.005.
34 Molenaar JJ, Domingo-Fernández R, Ebus ME, et al.LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression[J].Nat Genet, 2012, 44(11):1199-1206.DOI:10.1038/ng.2436.
35 Nguyen LH, Zhu H.Lin28 and let-7 in cell metabolism and cancer[J].Transl Pediatr, 2015, 4(1):4-11.DOI:10.3978/j.issn.2224-4336.2015.01.05.
36 Thornton JE, Gregory RI.How does Lin28 let-7 control development and disease[J].Trends Cell Biol, 2012, 22(9):474-482.DOI:10.1016/j.tcb.2012.06.001.
37 Rehfeld F, Rohde AM, Nguyen DTT, et al.Lin28 and let-7:ancient milestones on the road from pluripotency to neurogenesis[J].Cell Tissue Res, 2015, 359(1):145-160.DOI:10.1007/s00441-014-1872-2.
38 Mayr F, Heinemann U.Mechanisms of Lin28-Mediated miRNA and mRNA Regulation-A Structural and Functional Perspective[J].Int J Mol Sci, 2013, 14(8):16532-16553.DOI:10.3390/ijms140816532.
39 Nam Y, Chen C, Gregory RI, et al.Molecular basis forinteraction of let-7 microRNAs with Lin28[J].Cell, 2011, 147(5):1080-1091.DOI:10.1016/j.cell.2011.10.020.
40 Jiang S, Baltimore D.RNA-binding protein Lin28 in cancer and immunity[J].Cancer Lett, 2016, 375(1):108-113.DOI:10.1016/j.canlet.2016.02.050.
41 Wang X, Cao L, Wang Y, et al.Regulation of let-7 and its target oncogenes (Review)[J].Oncol Lett, 2012, 3(5):955-960.DOI:10.3892/ol.2012.609.
42 Chen C, Cao F, Bai L, et al.IKK Enforces a LIN28B/TCF7L2 Positive Feedback Loop That Promotes Cancer Cell Stemness and Metastasis[J].Cancer Res, 2015, 75(8):1725-1735.DOI:10.1158/0008-5472.CAN-14-2111.
43 Feng S, Huang S, Tong Y, et al.RNA-binding protein LIN28 is a sensitive marker of pediatric yolk sac tumors[J].Pediatr Surg Int, 2016, 32(8):819-825.DOI:10.1016/j.canlet.2016.02.050.
44 Balzeau J, Menezes MR, Cao S, et al.The LIN28/let-7 Pathway in Cancer[J].Front Genet, 2017, 8:31.DOI:10.3389/fgene.2017.00031.
45 Gell JJ, Zhao J, Chen D, et al.PRDM14 is expressed in germ cell tumors with constitutive overexpression altering human germline differentiation and proliferation[J].Stem Cell Res, 2018, 27:46-56.DOI:10.1016/j.scr.2017.12.016.
46 Poynter JN, Hooten AJ, Lindsay Frazier A, et al.Associations between variants in KITLG, SPRY4, BAK1, and DMRT1 and pediatric germ cell tumors[J].Genes Chromosomes Cancer, 2012, 51(3):266-271.DOI:10.1002/gcc.20951.
47 Frazier AL, Weldon C, Amatruda J.Fetal and neonatal germ cell tumors[J].Semin Fetal Neonatal Med, 2012, 17(4):222-230.DOI:10.1016/j.siny.2012.05.004.
48 Cusack M, Scotting P.DNA methylation in germ cell tumour aetiology:current understanding and outstanding questions[J].Reproduction, 2013, 146(2):R49-R60.DOI:10.1530/REP-12-0382.
49 Amatruda JF, Ross JA, Christensen B, et al.DNA methylation analysis reveals distinct methylation signatures in pediatric germ cell tumors[J].BMC Cancer, 2013, 13:313.DOI:10.1186/1471-2407-13-313.
50 Kato N, Shibuya H, Fukase M, et al.Involvement of adenomatous polyposis coli (APC) gene in testicular yolk sac tumor of infants[J].Hum Pathol, 2006, 37(1):48-53.DOI:10.1016/j.humpath.2005.09.008.
51 Furukawa S, Haruta M, Arai Y, et al.Yolk sac tumor but not seminoma or teratoma is associated with abnormal epigenetic reprogramming pathway and shows frequent hypermethylation of various tumor suppressor genes[J].Cancer Sci, 2009, 100(4):698-708.DOI:10.1111/j.1349-7006.2009.01102.x.
52 Rosa A, Spagnoli FM, Brivanlou AH.The miR-430/427/302 Family Controls Mesendodermal Fate Specification via Species-Specific Target Selection[J].Dev Cell, 2009, 16(4):517-527.DOI:10.1016/j.devcel.2009.02.007.
53 Poynter JN, Bestrashniy JRBM, Silverstein KAT, et al.Cross platform analysis of methylation, miRNA and stem cell gene expression data in germ cell tumors highlights characteristic differences by tumor histology[J].BMC Cancer, 2015, 15:769.DOI:10.1186/s12885-015-1796-6.
54 Fustino N, Rakheja D, Ateek CS, et al.Bone morphogenetic protein signalling activity distinguishes histological subsets of paediatric germ cell tumours[J].Int J Androl, 2011, 34(4pt2):e218-e233.DOI:10.1111/j.1365-2605.2011.01186.x.
55 Murray MJ, Saini HK, van Dongen S, et al.The two most common histological subtypes of malignant germ cell tumour are distinguished by global microRNA profiles, associated with differential transcription factor expression[J].Mol cancer, 2010, 9:290.DOI:10.1186/1476-4598-9-290.
56 Sievers S, Alemazkour K, Zahn S, et al.IGF2/H19 imprinting analysis of human germ cell tumors (GCTs) using the methylation-sensitive single-nucleotide primer extension method reflects the origin of GCTs in different stages of primordial germ cell development[J].Genes Chromosomes Cancer, 2005, 44(3):256-264.DOI:10.1002/gcc.20237.
57 Williams LA, Pankratz N, Lane J, et al.Klinefelter syndrome in males with germ cell tumors:A report from the Children’s Oncology Group[J].Cancer, 2018, 124(19):3900-3908.DOI:10.1002/cncr.31667.
58 de Marqui AB, da Silva-Grecco RL, Balarin MA.Prevalence of Y-chromosome sequences and gonadoblastoma in Turner syndrome[J].Rev Paul Pediatr, 2016, 34(1):114-121.DOI:10.1016/j.rppede.2015.12.004.
59 Piazza MJ, Urbanetz AA.Germ Cell Tumors in Dysgenetic Gonads[J].Clinics, 2019, 74:e408.DOI:106061/clinics/2019/e408.
60 Hall C, Ritz B, Cockburn M, et al.Risk of malignant childhood germ cell tumors in relation to demographic, gestational, and perinatal characteristics[J].Cancer Epidemiol, 2017, 46:42-49.DOI:10.1016/j.canep.2016.12.002.
61 Le Cornet C, Fervers B, Pukkala E, et al.Parental Occupational Exposure to Organic Solvents and Testicular Germ Cell Tumors in their Offspring:NORD-TEST Study[J].Environ Health Perspect, 2017, 125(6):067023.DOI:10.1289/EHP864.
62 Hall C, Heck JE, Ritz B, et al.Prenatal Exposure to Air Toxics and Malignant Germ Cell Tumors in Young Children[J].J Occup Environ Med, 2019, 61(6):529-534.DOI:10.1097/JOM.0000000000001609.

备注/Memo

收稿日期:2020-10-05。
基金项目:国家自然基金面上项目(编号:82072782)
通讯作者:董瑞,Email:rdong@fudan.edu.cn

更新日期/Last Update: 1900-01-01